Document:

Exhibit 10.1

 

EMPLOYMENT AGREEMENT

 

EMPLOYMENT AGREEMENT, entered into as of May 9, 2016 (the "Agreement"), by and between HealthWarehouse.com, Inc., a Delaware corporation (the "Company"), and Lalit Dhadphale (the "Employee").

 

W I T N E S S E T H:

 

WHEREAS, the Company desires to employ the Employee as its President and Chief Executive Officer so that it will have the benefit of his ability, experience and services, and the Employee is willing to enter into an agreement to that end, upon the terms and conditions hereinafter set forth.

 

NOW, THEREFORE, in consideration of good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby covenant and agree as follows:

 

1.       Employment

 

The Company hereby agrees to employ the Employee, and the Employee hereby agrees to be in the employ of the Company, on and subject to the terms and conditions of this Agreement.

 

2.       Term

 

The period of this Agreement (the "Agreement Term") shall commence and become effective on May 9, 2016 (the "Effective Date") and shall expire on the first anniversary of the Effective Date.  Thereafter, the Agreement Term shall be automatically extended for an additional year on each anniversary of the Effective Date, unless written notice of non-extension is provided by either party to the other party at least ninety (90) days prior to such anniversary.  The period of the Employee's employment hereunder (the "Employment Period") shall commence as of the Effective Date and shall expire at the end of the Agreement Term, unless earlier terminated in accordance with the terms and conditions of this Agreement or except as otherwise set forth herein.

 

3.       Position and Duties

 

(a)      Position, Reporting.  During the Employment Period, the Employee shall serve as, and with the title, office and authority of, the President and Chief Executive Officer of the Company.  The Employee shall have such duties and authority as are normally associated with such positions and will generally have responsibility for managing Company activities, subject to the authority of the Company's Board of Directors of the Company (the "Board"). These activities include but are not limited to Board activities, investor and public relations, fund raising and banking relations. The Employee shall report directly to the Board.

 

 

 

 

Page 1 of 9

 

 

 

 

(b)       Business Time.  During the Employment Period, the Employee agrees to devote his full business time, efforts and skills to the performance of his duties and responsibilities under this Agreement.  Subject to Section 7 hereof, the Employee shall not be precluded from devoting reasonable periods of time to participate in professional, philanthropic or community activities; provided that such activities do not interfere with the Employee's regular performance of his duties and responsibilities hereunder.

 

(c)       Location.  The Employee shall perform his duties in the Florence, Kentucky and Las Vegas, Nevada areas and from time to time the Employee will be required to travel to other locations in connection with his responsibilities under this Agreement.

 

4.         Compensation and Benefits

 

In consideration of the services rendered by the Employee during the Employment Period, and subject in all respects to the terms and provisions of this Agreement, the Company shall pay or provide the Employee the compensation and benefits set forth below:

 

(a)        Base Salary.  During the Employment Period, the Company shall pay the Employee a base salary at the rate of $175,000 per annum (the "Base Salary"), to be paid in accordance with the normal payroll practices of the Company.  The Base Salary shall be increased to $185,000 per year on May 9, 2017 and thereafter may be reviewed from time to time by the Compensation Committee of the Board (the "Compensation Committee") for possible merit increases.

 

(b)        Annual Bonus.  During the Employment Period, the Employee shall have the opportunity to earn an annual bonus (the "Annual Bonus") with a target equal to 100% of Base Salary under the annual bonus program in which management employees of the Company are eligible to participate, as determined by the Compensation Committee from time to time, with the amount and payment of the Annual Bonus to be based on the achievement of performance goals by the Company and/or the Employee under the terms of such program.  The Annual Bonus shall be paid 50% in cash and 50% in stock options. Notwithstanding the foregoing, for the 2016 and 2017 calendar years, the Employee shall be deemed to have earned at least a minimum Annual Bonus of 30% of Base Salary irrespective of whether applicable performance targets are met.  To be eligible for payment of the Annual Bonus, Employee must be employed by the Company on the date of payment of such Annual Bonus.  The Annual Bonus shall be paid no later than June 30 of the calendar year immediately following the calendar year to which such bonus relates.

 

(c)         Benefits.  The Employee shall be entitled to participate in the employee and fringe benefit plans and programs of the Company in which employees of the Company are generally eligible to participate from time to time during the Employment Period, subject to and on a basis consistent with the terms, conditions, eligibility requirements and overall administration of such plans and programs.

 

 

 

 

 

Page 2 of 9

 

 

 

 

(d)         Vacation.  The Employee shall be entitled to up to four (4) weeks of vacation per year.

 

(e)          Business Expenses.  The Company shall reimburse all reasonable business expenses and disbursements incurred by the Employee in the performance of his duties under this Agreement in accordance with the Company's normal practices and procedures, upon proper accounting therefor.

 

5.           Termination of Employment

 

The Employment Period and the Employee's employment hereunder shall be terminated upon the occurrence of any of the following events, subject to the provisions of this Agreement applicable to termination of employment, as follows:

 

(a)          Resignation for Good Reason.  The Employee may voluntarily terminate the Employment Period and the Employee's employment hereunder for Good Reason.  For these purposes of this Agreement, "Good Reason" shall mean (i) the assignment to the Employee of any duties materially inconsistent with the Employee's position, title, authority or responsibilities as contemplated by Section 3(a) hereof, or any action by the Company that results in a material diminution in such position, title, authority or responsibilities without the Employee's express written consent or (ii) a change in control wherein individuals who, as of the date of the signing of this Agreement, constitute the Board of Directors (the "Incumbent Board") cease for any reason to constitute at least a majority of such Board; provided that any individual who becomes a director of the Company subsequent to the date of the signing of this Agreement, whose election, or nomination for election by the Company stockholders, was approved by the vote of at least a majority of the directors then in office shall be deemed a member of the Incumbent Board.  In no event shall the Employee be considered to have terminated his employment for "Good Reason" unless the Employee delivers a written notice of termination to the Company identifying in reasonable detail the acts or omissions constituting "Good Reason" and the provision of this Agreement relied upon, and such acts or omissions are not cured by the Company within 15 days of receipt of such notice.  If the acts or omissions are not cured, the Employee may terminate his employment not earlier than 30 days following the date of the written notice of termination referred to in the preceding sentence

 

(b)          Resignation without Good Reason.  The Employee may voluntarily terminate the Employment Period and the Employee's employment hereunder for any reason that does not constitute Good Reason ("Without Good Reason") by giving the Company 30 days advance written notice of such termination. 

 

(c)          Termination For Cause.  The Company may terminate the Employment Period and the Employee's employment hereunder for Cause.  For purposes of this Agreement, "Cause" shall mean the occurrence of one of the following: (i) fraud or willful or intentional misrepresentation in connection with the Employee's performance of his duties hereunder; (ii) the failure by the Employee to substantially perform his duties hereunder; (iii) willful or intentional conduct by the Employee that is detrimental to the Company's reputation, goodwill or business operations in any material respect; (iv) breach or threatened breach by the Employee of the restrictive covenants incorporated in Section 7 hereof; (v) the Employee's conviction for, or plea of nolo contendere to a charge of commission of, a felony or a violation of federal or state securities laws; or (vi) a material breach of the representations in Section 9 hereof.

 

 

 

 

Page 3 of 9

 

 

 

 

(d)         Termination Without Cause.  The Company may terminate the Employment Period and the Employee's employment hereunder without Cause ("Termination Without Cause") at any time by giving the Employee 30 days' advance written notice of such termination, or in lieu thereof by paying the Employee, in addition to any amounts the Employee is due under Section 6 hereof, his then-current daily Base Salary for each day the Company's written notice of termination is less than 30 days.

 

(e)          Disability.  The Employment Period and the Employee's employment hereunder shall terminate upon his Disability.  For purposes of this Agreement, "Disability" shall mean the inability of the Employee to perform his essential duties to the Company, with or without accommodation, on account of physical or mental illness or incapacity for a period of three consecutive months, or for a period of six months, whether or not consecutive, during any 12-month period.  The Employee's employment hereunder shall be deemed terminated by reason of Disability on the last day of the applicable period.

 

(f)           Death.  The Employment Period and the Employee's employment hereunder shall terminate upon his death.

 

6.            Rights Upon Termination

 

In the event the Employment Period and the Employee's employment hereunder is terminated during the Agreement Term, the Employee shall have the rights provided below.

 

(a)           Resignation for Good Reason; Termination Without Cause.  In the event that the Employment Period and the Employee's employment hereunder is terminated by the Employee for Good Reason or by the Company as a Termination Without Cause, the Company shall pay the Employee: (i) any earned but unpaid Base Salary through the date of termination, (ii) any unreimbursed business expenses as of the date of termination under Section 4(e) hereof and (iii) subject to Section 6(d) below, severance pay equal to twelve (12) months of Base Salary at the rate then in effect, payable in equal installments over a twelve month period following the date of termination in accordance with the normal payroll practices of the Company.

 

(b)           Resignation Without Good Reason; Termination for Cause; Death; Disability.  In the event that the Employment Period and the Employee's employment hereunder is terminated by the Employee Without Good Reason, by the Company for Cause or on account of death or Disability, the Employee shall not be entitled to receive, and the Company shall have no obligation to provide, any severance payments, bonus, or benefits under this Agreement; except that the Company shall pay the Employee: (i) any earned but unpaid Base Salary through the date of termination, and (ii) any unreimbursed business expenses as of the date of termination under Section 4(e) hereof.

 

(c)           Other Obligations.  The benefits payable to the Employee under this Agreement are not in lieu of any benefits payable under any employee benefit plan, program or arrangement of the Company, except as specifically provided herein, and upon termination of employment, the Employee will receive such benefits or payments, if any, as he may be entitled to receive pursuant to the terms and conditions of such plans, programs and arrangements.  Except for the obligations of the Company provided by this Section 6, the Company shall have no other obligations to the Employee upon his termination of employment.

 

(d)            Releases of Claims.  As a condition of the Employee's entitlement to any severance payment under Section 6(a) hereof, the Employee to execute and honor a release of claims in the form specified by the Company.

 

 

 

 

Page 4 of 9

 

 

7.        Restrictive Covenants

 

(a)       Nondisclosure of Confidential Information.

 

(i)      The Employee acknowledges that during the course of the Employee's employment with the Company, the Employee has had or will have access to and knowledge of certain information that the Company considers confidential, and the release of such information to unauthorized persons would be extremely detrimental to the Company.  As a consequence, the Employee hereby agrees and acknowledges that the Employee owes a duty to the Company not to disclose, and agrees that without the prior written consent of the Company, at any time, either during or after the Employee's employment with the Company, the Employee will not communicate, publish or disclose, to any person anywhere or use, any Confidential Information (as hereinafter defined), except as may be necessary or appropriate to conduct the Employee's duties hereunder, provided the Employee is acting in good faith and in the best interest of the Company, or as may be required by law or judicial process.  The Employee will use reasonable best efforts at all times to hold in confidence and to safeguard any Confidential Information from falling into the hands of any unauthorized person.  The Employee will return to the Company all Confidential Information in the Employee's possession or under the Employee's control whenever the Company shall so request, and in any event will promptly return all such Confidential Information if the Employee's relationship with the Company is terminated for any or no reason and will not retain any copies thereof.  For purposes hereof, the term "Confidential Information" shall mean any information used by or belonging or relating to the Company or any of its affiliates that is not known generally to the industry in which the Company is or may be engaged and which the Company maintains on a confidential basis, including, without limitation, any and all trade secrets and proprietary information, information relating to the Company's business and services, employee information, customer lists and records, business processes, procedures or standards, know-how, manuals, business strategies, records, financial information, in each case whether or not reduced to writing or stored electronically, as well as any information that the Company advises the Employee should be treated as confidential information.  Further, Confidential Information shall not include information which is independently obtained from a third party whose disclosure violates no duty of confidentiality to the Company.

 

(ii)        The Employee acknowledges and agrees that all analyses, reports, proposals, software, documentation, machine code and other intellectual property owned by the Company (collectively, the "Company's Intellectual Property") are and shall remain the sole and exclusive property of the Company, or as otherwise may be noted, and that in no event shall the Employee have any ownership interest therein.  In that connection, the Employee hereby irrevocably assigns, transfers and conveys to the Company all of his right, title and interest, if any, in and to the Company's Intellectual Property, including any rights the Employee may have of patent, copyright, trade secret or other proprietary rights in the Company's Intellectual Property.  The Employee agrees to assist the Company in every proper way to obtain and from time to time enforce patents, copyrights, trade secrets and all other proprietary and intellectual property rights and interest in and to all the Company's Intellectual Property in any and all countries, and to that end the Employee will execute and deliver all documents and other papers and materials for use in applying for, obtaining and enforcing such patents, copyrights, trademarks and other proprietary and intellectual property rights and interests, as the Company may request in writing, together with any assignments thereof to the Company or persons designated by it.  The Employee agrees that the Company is appointed as his attorney to execute all such instruments and do all such things for the purpose of assuring to the Company (or its designee) the full benefit of the provisions of this paragraph.

    

(b)        Noninterference with Clients or Employees.  The Employee agrees that, during the period of the Employment Period and for a period of 18 months from the date of termination of employment for any reason (the "Restricted Period"), the Employee shall not, on the Employee's own behalf or on behalf of any other person or entity, solicit or in any manner influence or encourage any current or prospective client, customer, employee or other person or entity that has a business relationship with the Company or any subsidiary, to terminate or limit in any way their relationship with the Company, or interfere in any way with such relationship.

 

 

 

 

Page 5 of 9

 

 

 

 

(c)         Noncompetition.  The Employee agrees that, during the Restricted Period, the Employee shall neither directly nor indirectly, engage or hold an interest in any business engaged in the Business in those geographic areas in which the Company or its subsidiaries conduct the Business, nor directly or indirectly, have any interest in, own, manage, operate, control, be connected with as a stockholder (other than as a stockholder of less than five percent (5%) of the issued and outstanding stock of a publicly held corporation), joint venturer, officer, director, partner, employee or consultant, or otherwise engage or invest or participate in the Business in those geographic areas in which the Company or its subsidiaries engage in the Business.  For purposes of this Agreement, "Business" shall mean (i) the marketing and distribution of pharmaceuticals, prescription medications and over-the-counter ("OTC") medications and products and pet prescription medications in all 50 states and the District of Columbia through the mail or a commercial delivery service, and (ii) any other business in which the Company or its subsidiaries are engaged in during the Restricted Period.

 

(d)          Survival.  The provisions of this Section 7 shall be applicable and shall survive for the time periods specified herein without regard to the termination of the Employment Period or the expiration of the Agreement Term.

 

(e)          Enforcement.  The Employee acknowledges and agrees that the provisions of this Section 7 are reasonable and necessary for the successful operation of the Company.  The Employee further acknowledges that if he breaches any provision of this Section 7, the Company will suffer irreparable injury.  It is therefore agreed that the Company shall have the right to enjoin any such breach or threatened breach, without posting any bond, if ordered by a court of competent jurisdiction.  The existence of this right to injunctive and other equitable relief shall not limit any other rights or remedies that the Company may have at law or in equity including, without limitation, the right to monetary and compensatory damages.  In addition, the Employee further acknowledges that if he breaches any provision of this Section 7 following his termination of employment with the Company, the Employee will forfeit the right to any unpaid severance or other payments due under this Agreement.  If any provision of this Section 7 is determined by a court of competent jurisdiction to be unenforceable in the manner set forth herein, the Employee and the Company agree that it is the intention of the parties that such provision should be enforceable to the maximum extent possible under applicable law.  If any provisions of this Section 7 are held to be invalid or unenforceable, such invalidation or unenforceability shall not affect the validity or enforceability of any other provision of this Section 7 (or any portion thereof).  For purposes of the restrictions of this Section 7, references to the "Company" include reference to its subsidiaries and affiliates.

 

8.           Successors and Assigns

 

(a)          This Agreement shall inure to the benefit of and be binding upon the successors and assigns of the Company upon any sale of all or substantially all of the Company's assets, or upon any merger, consolidation or reorganization of the Company with or into any other corporation, all as though such successors and assigns of the Company and their respective successors and assigns were the Company.  Except as provided above, this Agreement shall not be assignable by the Company to any person without the prior written consent of the Employee.

 

(b)           This Agreement and all rights of the Employee hereunder shall inure to the benefit of and be enforceable by the Employee's personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.  The Employee's obligations under this Agreement shall not be assignable by the Employee.

 

9.             Representations

 

The Employee represents and warrants that his entering into this Agreement and his employment with the Company will not be in breach of any other agreement with any current or former employer and that he is not subject to any other restrictions on solicitation of clients or customers or competing against another entity.  The Employee understands that the Company has relied on this representation in entering into this Agreement.

 

 

 

 

Page 6 of 9

 

 

 

 

10.       Board Membership

 

At each annual meeting of the Company's stockholders during the Employment Period, the Company will nominate Employee to serve as a member of the Board.  Employee's service as a member of the Board will be subject to any required stockholder approval.  Upon the termination of Employee's employment for any reason, unless otherwise requested by the Board, Employee agrees to resign from the Board (and all other positions held at the Company and its affiliates), and Employee, at the Board's request, will execute any documents necessary to reflect his resignation.

 

11.       Entire Agreement

 

This Agreement contains the entire understanding of the parties with respect to the subject matter hereof and cancels and supersedes any and all prior agreements between the parties with respect to the subject matter hereof, except to the extent specifically provided herein.  Any amendment or modification of this Agreement shall not be binding unless in writing and signed by the Company and the Employee.  The Company represents that there are no other agreements with the Company or other undertakings to or for the Company which have been executed by the Employee other than as expressly set forth herein.

 

12.       Severability

 

In the event that any provision of this Agreement is determined to be invalid or unenforceable, the remaining terms and conditions of this Agreement shall be unaffected and shall remain in full force and effect, and any such determination of invalidity or unenforceability shall not affect the validity or enforceability of any other provision of this Agreement.

 

13.       Tax Withholding

 

All compensation paid to the Employee under this Agreement shall be subject to all applicable income tax, employment tax and all other federal, state and local tax withholdings and deductions.

 

14.       Waiver of Breach

 

The waiver by either party of a breach of any provision of this Agreement by the other party must be in writing and will not operate or be construed as a waiver of any subsequent breach by such other party.

 

15.       Notices

 

All notices which may be necessary or proper for either the Company or the Employee to give to the other shall be in writing and shall be delivered by hand or sent by registered or certified mail, return receipt requested, or by air courier, to the Employee at:  the Employee's then-current address as listed in the Company's payroll records or at such other address as may be provided to the Company for this purpose, and shall be sent in the manner described above to Chief Operating Officer and Chief Financial Officer, HealthWarehouse.com, Inc., 7107 Industrial Road, Florence, Kentucky, 41042, and shall be deemed given when sent, provided that any notice given under Section 5 hereof shall be deemed given only when received.  Any party may by like notice to the other party change the address at which he or they are to receive notices hereunder.

 

 

 

 

Page 7 of 9

 

 

 

 

16.         Governing Law

 

This Agreement shall be governed by and enforceable in accordance with the laws of the Commonwealth of Kentucky, without giving effect to the principles of conflict of laws thereof.

 

17.         Counterparts

 

This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.

 

18.         Drug Screen

 

This Agreement is contingent upon the Employee's successful completion of a pre-employment drug screen.  In the event that, for any reason, such drug screen shall not be successfully completed, this Agreement shall be null and void and the Company and the Employee shall have no obligations hereunder.

 

 

 

 

 

 

 

  

Page 8 of 9

 

  

IN WITNESS WHEREOF, the Company and the Employee have executed this Agreement as of May 9, 2016.

 

EMPLOYEE

 

 

 

 

_/s/ Lalit Dhadphale                                                                    

       Lalit Dhadphale

 

 

HEALTHWAREHOUSE.COM, INC.

 

 

 

 

_/s/    Daniel Seliga                                                                        

By:     Daniel Seliga

Title:   Chief Operating Officer

 

 

 

 

 

 

 

 

 

 

Page 9 of 9May 12, 2016 Exhibit 10.1

    EXHIBIT 10.1

Adelaide Agribusiness

   908 US 22-28 King William St Adelaide

   SA 5000

   Ph: 08 8407 6181

   Fax: 08 8407 6280

28 April 2016

The Secretary

   Seed Genetics International Pty Ltd 5 13-15 King William Rd

   UNLEY SA 5061

Business Letter of Advice for Seed Genetics International Pty Ltd ACN/ARBN/ABN 44061114814

                                                     ("you")

I'm writing today to let you know of some changes that are being made to your facilities. Please review the changes as detailed at the end of this letter and then read below to understand
when these changes will take effect.

Unless otherwise stated, these changes take effect once we receive a signed copy of this letter duly signed, provided we receive it within 30 days of the date of this letter.

We recommend that you keep this letter in a safe place in case you want to refer to it in the future. 

If you have any questions, please feel free to call me on 08 8407 6181. I'd be happy to help.

Thank you again for choosing to work with NAB.

      /s/ Barry Willhelm

Agribusiness Manager

   

   

   

Changes to facilities

The information in this letter is current as at the date of this letter and some of this information
may be subject to change, Words printed like This have the same meaning as they do in your current terms and conditions.
This letter Is a Transaction Document for the purposes of your Agreement with NAB.

	
Facility
	
Trade Refinance Facility 

	
Existing Facility Limit
	
AUD 12,000,000.00 

	
Extension
	
This facility will be extended.

	 	
New expiry date30/03/2018

 

	 	
If this facility is subject to financial, reporting or other covenants or undertakings, we may review your compliance with those covenants or undertakings
separately. This letter is not a waiver of any rights we may have if those covenants or
undertakings are not met.

 

	
Facility
	
NAB  Business Markets - Flexible Rate Loan

	
Existing Facility Limit
	
$650,000.00

	
Facility Limit Change
	
The facility limit for this facility will change.

	 	
New facility limit: $800,000.00

	 	
It Is your responsibility to ensure that the new facility limit is not exceeded.

Changes to Covenants

Additional Lending Covenants

Minimum capital adequacy of 30.00% as measured on a daily basis and reported in relation to the 12 month period ending on 31st December annually for Seed Genetics International Pty Ltd.

To be reported on by the 15th February annually via the December quarterly management reports. Capital adequacy
being tangible net worth + intercompany loans from S&W divided by total tangible assets.

Signed contract for sale to be provided for Keith land purchases 4 weeks before settlement to enable documentation and funding to be scheduled.

Borrowing Base Facility agreed Inventory 'Selling Price' for stock value calculation is to be confirmed at annual review by the Bank by 31 March each year.

Stock harvested in prior calendar year is to be excluded from Borrowing Base Facility approved inventory from 31 December of the calendar year following harvest.

These additional lending covenants apply in relation to all facilities provided to you by NAB.

All other lending covenants set out in your Agreement (as amended from time to time), remain in place.

                                                       2

Lending Covenants to be removed

No dividends are to be paid in respect of Seed Genetics International Pty Ltd without the prior written consent of the Bank.

Market Rate 'stock' facility limit to reduce to $7,000,000 by no later than 31/10/2014.

Monthly stock reports to be provided with 15 days of months end. Maximum drawdown
under Market Rate Facility to be 36% of sales price. The agreed forecast harvest price for
2013 & 2014 harvest is $6.20 per kg. This price is locked in until agreement on setting for the succeeding years harvest.

Minimum capital adequacy of 30.00% as measured on a daily basis and reported in relation to the 12 month period
ending on 31st December annually for Seed Genetics International Pty Ltd. To be reported on by the 15th February annually via the
December quarterly management reports.

Final FYE 2014 Accounts for Seed Genetics International Pty Ltd at to be provided by no later than 30th April 2015.

Progress payments for the construction of the industrial shed situate at 4 & 5 Stirling Road Keith SA to be made via approved invoices (that correlate to the fixed price building contract).
National Australia Bank internal staff to review work completed and vet payment at each
stage.

Market Rate 'stock' facility limit to reduce to $6,500,000 by no later than 31/12/2014. Market Rate 'stock ' facility limit to reduce to $6,000,000 by no later than 30/11/2014.

Drawdowns under the MRF facility are to be exclusively for the purchase of seed from growers.

Current seasonal stock facility is to be fully cleaned down by 30th September of the following year, approx 16 month clean down period. At the start of each season a separate facility is to be
drawn, providing a clear distinction between the current & past seasonal facilities. Should the past seasonal facility not fully clean down by September of the following calendar year, the
borrower is to provide to NAB, within 5 business days a strategy to fully clean down the facility, acceptable to NAB.

No further grower payments over or above budgeted payments are to be made without the prior written consent of the Bank.

The Borrower is to provide to the Bank a copy of the Trade Credit Insurance Policy from an insurer who is on the Bank's panel of acceptable insurers with fully policy details and buyer limits
including NAB noted as 'Financier noted/first loss payee'.

All terms and conditions outlined in the SCF Support Paper dated 5/3/2015 are to be strictly adhered too. Trade paper is to be signed by SCF Director (Andre Taye).

These lending covenants no longer apply. Please note that all other lending covenants set out in your Agreement (as amended from time to time), remain in place.

                                                       3

Fees and charges

The following fees are payable by you immediately on your acceptance of this letter.

Unless otherwise stated, these fees are in addition to any other fees set out in the terms and conditions applicable to any of the
facilities and any other fees listed in the relevant fees guide.

Estimate of NAB's credit fees and charges

	
Application fee
	
$ 750.00

	 	
This application fee is the total application fee payable under this Agreement. It includes any separate
facility application fees set out in the Facility Details.

	
Company search fee
	
$ 40.00

	
Estimate of Government charges (payable to the relevant government department)
	 
	
Personal Property Securities registration fee
	
$ 22.47

	
Other Fees and charges (payable to third parties)
	 
	
Estimate of total amount of credit fees and charges to establish the facilities (as far as can be ascertained now). These fees (if any) are payable by you
immediately (unless NAB otherwise tells you), if not already paid. Any additional fees and charges to establish the facilities will be advised to you and are payable on
demand.
	
$ 812.47

Acceptance

To accept this Letter of Advice, you must sign the duplicate and return it to us before any deadline for acceptance set out at the start of this letter.

If provision is made for guarantors to sign the duplicate of this letter, then each such guarantor must also sign the duplicate.

By executing this document, you:

	accept each change set out in this letter;
	acknowledge and agree that, unless otherwise expressly stated, all security provided to NAB remains in place, and can continue to be relied on by NAB, including in relation to any facility
varied by this letter; and
	confirm that you understand that any secured property will be at risk if the borrower or any guarantor defaults.

                                                       4

Signed by the Borrower

Signature Section for Companies

Seed Genetics International Pty Ltd

Customer Company Name (BLOCK LETTERS)

Executed by the company named above in accordance with Section 127 of the Corporations Act 2001 (Cwith)

	
/s/ Andrew Ross Carthew
	 	
/s/ Dennis Jury

	
Signature
	 	
Signature

	
ANDREW ROSS CARTHEW
	 	
DENNIS JURY

	
Full name (BLOCK LETTERS)
	 	
Full name (BLOCK LETTERS)

	
Secretary*
	 	
Director

	
Office Held
	 	
Office Held

	
May 6, 2016
	 	
06/05/16

	
Date
	 	
Date

o    * Please tick here if you are signing as Sole Director and Sole Company Secretary

   

   

   

   

                                                       5

Changes to General Conditions

The General Conditions forming part of your Agreement with NAB are varied to include the following provisions. All other General Conditions set out
in your Agreement (as amended from time to time) remain in place.

1.  Protecting NAB's Security Position

(a)    If:

(i)    a PPS Law applies, or will at a future date apply to any of the Transaction Documents or any of the transactions contemplated by them, or NAB determines that a PPS
Law applies, or will at a future date apply, to any of the Transaction Documents or any of the transactions contemplated by them; and

(ii)    in the opinion of NAB, the PPS Law adversely affects or would or may adversely affect NAB's security position or the rights or obligations of NAB under or in connection with the Transaction
Documents,

NAB may from time to time give notice to you requiring you to do anything, including

(iii)    promptly providing all necessary information (including serial numbers) and taking all necessary action (including obtaining any consent or agreement or giving any notice)
to enable NAB to register fully valid and effective financing statements or financing change
statements (each as defined in the PPSA) with respect to any Security Interest held or intended to be held by NAB under the Transaction Documents at any time;

(iv)    amending any Transaction Document or executing any new Transaction Document; and

(v)    to continuously perfect any security interest in respect of which you are or may become the secured party in such manner and by such time as NAB may direct so as to achieve the priority
over competing security interests and other claims and protection against loss, extinguishment and diminution of the security interest,

that in NAB's opinion is necessary to ensure that, to the maximum possible extent, NAB's security position, and rights and obligations, are not adversely affected as contemplated
by paragraph (ii) (or that any such adverse effect is overcome to the maximum extent possible). You must comply with the
requirements of that notice within the time stipulated in the notice.

(b)    In this clause and in clause 3, PPS Law means:

(i)the PPSA;

(ii)any regulations made at any time under the PPSA;

(iii)any provision of the PPSA or regulations referred to in paragraph (i) or (ii); 

(iv)any amendment to any of the above, made at any time; or

(v)any amendment made at any time to the Corporations Act or any other legislation as a consequence of the PPSA.

2.  Fees

You must pay NAB and indemnify NAB for an amount equal to any Costs or Taxes in connection with preparing, registering and maintaining any financing statement or financing
change statement (each as defined in the PPSA) in relation to a Security, or taking any action that in NAB's opinion is necessary under clause 1 above.

                                                       6

3.  PPSA Waiver

You waive, to the extent permitted under the PPS Law, your right to receive any notices NAB is required to give under the PPS Law (including a notice of a verification
statement).

4.  Confidentiality

(a)    You agree and NAB agrees that neither party will disclose to an Interested Person, or any other person at the request of an Interested Person, any information of the kind described
in section 275(1) of the PPSA unless allowed or required by law.

(b)    You will not authorise the disclosure of any information of the kind described in section 275(1) of the PPSA.

(c)    Each party agrees not to disclose information provided by the other party (including the existence or contents of a Transaction Document) except:

(i)    to officers, employees, legal and other advisers and auditors of you, NAB or a Receiver;

(ii)    with the consent of the other party (who must not unreasonably withhold their consent);

(iii)    if required by any stock exchange or if allowed or required by law;

(iv)    by NAB under any other provision of a Transaction Document;

(v)    by NAB to any Related Entity of NAB or you;

(vi)    by NAB to any assignee of NAB's rights under a Transaction Document or any other arrangement (including a request, bill of exchange, agreement guarantee or a Security Interest) by or with
you under which obligations are or could in the future be owed to NAB;

(vii)    by NAB to any person in connection with NAB exercising rights or dealing with rights or obligations (including preparatory steps such as negotiating with
any potential assignee of NAB's rights or other person who is considering contracting with NAB or a Receiver in connection with a Transaction Document;

(viii)    by NAB for the purpose of registering and maintaining any financing statement or financing change statement (each as defined in the PPSA) relating to NAB's Security; or

(ix)    by NAB to any Debtor/Guarantor or person NAB believes may become a Debtor/Guarantor,

provided that the prohibition under clause 3(a) or 3(b) is absolute and therefore none of the exceptions in this clause 3(c)(i) - (viii) apply to a disclosure under clause 3(a) or 3(b).

(d)    NAB agrees that you accept this Letter of Advice on condition that NAB compiles with its obligations of confidentiality under clauses 3(a) and 3(c) above.

5.  Representations and Warranties

You represent and warrant to NAB that at the time of this Letter of Advice, and at all times thereafter, except as disclosed to and agreed to by NAB in writing, you are not a trustee of any Trust
or a partner in a partnership.

                                                       7

6.  Definitions

The following definitions apply to your Agreement with NAB:

(a)    Debtor/Guarantor means:

(i)    any person who guarantees or has provided a Security Interest to secure the payment of any part of the Balance Owing;

(ii)    If any part of the Balance Owing includes obligations you owe under a guarantee, the person whose obligations you guarantee and any other person who guarantees that other person's
obligations; and

(iii)    any other person you and NAB agree is to be a "Debtor/Guarantor" for the purpose of a Transaction Document.

(b)    Interested Person has the meaning given to that term for the purposes of section 275 of the PPSA, and includes:

(i)    any person granting a Security;

(ii)    a person with another Security Interest in the same property in which NAB has a Security;

(iii)    if a person granting a Security is a body corporate, an auditor of that person;

(iv)      an execution creditor with an interest in the property in which NAB has a Security;

(v)     an authorised representative of any of the above.

(c)    PPSA means the Personal Property Securities Act 2009 (Cwith).

(d)    Security Interest:

(i)    in relation to any personal property (as defined in the PPSA), has the same meaning as in the PPSA;

(ii)    in relation to any other property, means any security for the payment of money or performance of obligations including a lien, pledge, trust or power.

7.  Interpretation

In your Agreement with NAB, a reference to law means common law, principles of equity, and laws made
by parliament (and laws made by parliament include regulations and other instruments under them, and consolidations, amendments, re-enactments or replacements of
them). For example, a reference to a section or other provision of a law made by parliament
Includes any amendment or replacement of that section or provision, Including an
amendment to the number of that section or provision.

Changes to Specific Conditions

Global Trade Finance Specific Conditions

The Global Trade Finance Specific Conditions (if any) forming part of your Agreement with NAB are varied to include the following provisions. All other Specific Conditions (if any) set
out in your Agreement (as amended from time to time), remain in place.

1. Pledge

NAB may request that, as security for your obligations to NAB (whether in relation to the Facility or otherwise), you
authorise NAB to retain by way of pledge the document and goods relating to each Letter of Credit Drawn under a Facility. If requested by NAB, you agree to
execute any document necessary to grant NAB a Security Interest in the document and goods relating to such Letter of Credit (a "Pledge Agreement").

2. Additional consequences of default

If you are in Default, in addition to any other rights and obligations under the General Conditions or Global Trade Finance Specific Conditions, NAB may sell, dispose of or otherwise deal
with any documents or goods pledged under a Pledge Agreement as NAB thinks fit and apply the proceeds towards satisfaction of your obligations to NAB (whether in relation to the Facility or
otherwise).

                                                       8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00258-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00258-of-00352.parquet"}]]